Connection

Scott Lindhorst to Histone Deacetylase Inhibitors

Back to Details
This is a "connection" page, showing publications Scott Lindhorst has written about Histone Deacetylase Inhibitors.
Scott Lindhorst
Connection Strength
0.271
Histone Deacetylase Inhibitors
  1. Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastoma. Cancer Chemother Pharmacol. 2018 12; 82(6):945-952.
    View in: PubMed
    Score: 0.153
  2. Mechanisms and clinical significance of histone deacetylase inhibitors: epigenetic glioblastoma therapy. Anticancer Res. 2015 Feb; 35(2):615-25.
    View in: PubMed
    Score: 0.119
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.